Inhibrx - Stock Price History | INBX

Historical daily share price chart and data for Inhibrx since 2021 adjusted for splits. The latest closing stock price for Inhibrx as of September 27, 2021 is 36.26.
  • The all-time high Inhibrx stock closing price was 50.00 on December 17, 2020.
  • The Inhibrx 52-week high stock price is 50.97, which is 40.6% above the current share price.
  • The Inhibrx 52-week low stock price is 14.27, which is 60.6% below the current share price.
  • The average Inhibrx stock price for the last 52 weeks is 26.64.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Inhibrx Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 23.9004 20.6300 50.0000 15.9600 32.9700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.374B $0.013B
Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29